Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Thomas William Flaig

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Flaig, Thomas

One or more keywords matched the following items that are connected to Flaig, Thomas

Item Type	Name
Academic Article	A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer.
Academic Article	Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
Academic Article	Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
Academic Article	Prostate cancer in a man with multiple previous cancers.
Academic Article	Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial.
Academic Article	Management of the side effects of androgen deprivation therapy in men with prostate cancer.
Academic Article	Adjuvant medical therapy for prostate cancer.
Academic Article	A renaissance in the medical treatment of advanced prostate cancer.
Academic Article	Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.
Academic Article	Low-dose diethylstilbestrol for the treatment of advanced prostate cancer.
Academic Article	Optimizing outcomes of advanced prostate cancer: drug sequencing and novel therapeutic approaches.
Academic Article	Prostate cancer: celecoxib trampled in the STAMPEDE trial.
Academic Article	Increased survival with enzalutamide in prostate cancer after chemotherapy.
Academic Article	Optimal management of recurrent prostate cancer in older patients.
Academic Article	A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
Academic Article	Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.
Academic Article	A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
Academic Article	High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Academic Article	Bicalutamide-associated fulminant hepatotoxicity.
Academic Article	Silibinin suppresses CD44 expression in prostate cancer cells.
Academic Article	Abiraterone and increased survival in metastatic prostate cancer.
Academic Article	Redefining hormone sensitive disease in advanced prostate cancer.
Academic Article	Abiraterone in metastatic prostate cancer without previous chemotherapy.
Concept	Prostatic Neoplasms
Academic Article	Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer.
Academic Article	Sequencing medical therapy in prostate cancer: not as easy as 1-2-3.
Academic Article	The prognostic significance of Gleason scores in metastatic prostate cancer.
Academic Article	Geriatric considerations in the treatment of advanced prostate cancer.
Academic Article	Visceral metastases in prostate cancer: an underestimated and understudied subgroup.
Academic Article	Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Academic Article	Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
Academic Article	Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer.
Academic Article	Upfront Chemotherapy for Metastatic Prostate Cancer.
Academic Article	Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.
Academic Article	Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials.
Academic Article	Treatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world data.
Academic Article	Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
Academic Article	Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database.
Academic Article	Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Academic Article	Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Academic Article	Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.
Academic Article	Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction.
Academic Article	Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.
Academic Article	Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
Academic Article	Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.
Academic Article	Initiation of ADT in a Man With Locally Advanced Prostate Cancer and Multiple Cardiovascular Risk Factors.
Academic Article	Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer.
Academic Article	Point-Prostate Cancer Genomic Analysis: Routine or Research Only?
Academic Article	Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.
Concept	Prostatic Neoplasms, Castration-Resistant
Academic Article	Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.
Academic Article	Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study.
Academic Article	Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer.
Academic Article	Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.
Academic Article	TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.
Academic Article	KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer.
Academic Article	Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer.
Academic Article	Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study.
Academic Article	Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations.
Academic Article	Metabolic and cardiovascular disease risk for Zimbabwean men with prostate cancer receiving long-term androgen deprivation therapy.

Search Criteria

Prostatic Neoplasms